← All trials
NCT05289908
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 21, 2022
- Primary completion
- Dec 31, 2022
- Completion date
- Apr 30, 2023
- First posted
- Mar 22, 2022
- Last posted
- Sep 30, 2022
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jinlin UniversityLead sponsor
- Guangdong Medical UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
- Panjin Liaoyou Gem Flower HospitalCollaborator
- Guangzhou Medical UniversityCollaborator
- Jinlin UniversityOverall official - principal investigator
- Jinlin UniversityReponsible party - principal investigator
- Wuxi People's HospitalCollaborator
- Jinlin UniversitySponsor investigator
- Jinlin UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.